These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 19039836)

  • 1. Take steps to protect your heart during cancer treatment. Women with breast cancer are especially at risk, but there are things you can do to minimize the cardiovascular threat.
    Heart Advis; 2008 Oct; 11(10):6. PubMed ID: 19039836
    [No Abstract]   [Full Text] [Related]  

  • 2. Early breast cancer therapy and cardiovascular injury.
    Steinherz L
    J Am Coll Cardiol; 2008 Mar; 51(12):1235; author reply 1235. PubMed ID: 18355667
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug discovery for breast cancer and co-instantaneous cardiovascular disease: what is the future?
    Yin L; Hu Q
    Future Med Chem; 2013 Mar; 5(4):359-62. PubMed ID: 23495679
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiovascular complications of breast cancer therapy.
    Swain SM
    Clin Adv Hematol Oncol; 2008 Apr; 6(4):247-8, 282. PubMed ID: 18496491
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiotoxicity: trastuzumab and cancer survivors.
    Patanè S
    Int J Cardiol; 2014 Dec; 177(2):554-6. PubMed ID: 25205483
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention and management of major side effects of targeted agents in breast cancer.
    Metzger Filho O; Saini KS; Azim HA; Awada A;
    Crit Rev Oncol Hematol; 2012 Dec; 84 Suppl 1():e79-85. PubMed ID: 20817545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalizing cardiovascular disease prevention among breast cancer survivors.
    Singla A; Kumar G; Bardia A
    Curr Opin Cardiol; 2012 Sep; 27(5):515-24. PubMed ID: 22874128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of cardiovascular events in breast cancer patients receiving chemotherapy in clinical practice.
    Sukel MP; Breekveldt-Postma NS; Erkens JA; van der Linden PD; Beiderbeck AB; Coebergh JW; Herings RM
    Pharmacoepidemiol Drug Saf; 2008 Feb; 17(2):125-34. PubMed ID: 18058835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aromatase inhibitors and cardiac toxicity: getting to the heart of the matter.
    Gandhi S; Verma S
    Breast Cancer Res Treat; 2007 Nov; 106(1):1-9. PubMed ID: 17211535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer treatments may harm the heart. Doctors strive to prevent the cure for one disease from causing another.
    Harv Heart Lett; 2012 Aug; 22(12):1, 7. PubMed ID: 23025017
    [No Abstract]   [Full Text] [Related]  

  • 11. Managing treatment side effects in advanced breast cancer.
    Moore S
    Semin Oncol Nurs; 2007 Nov; 23(4 Suppl 2):S23-30. PubMed ID: 18054679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot study evaluating the role of cardiac magnetic resonance imaging in monitoring adjuvant trastuzumab therapy for breast cancer.
    Lawley C; Wainwright C; Segelov E; Lynch J; Beith J; McCrohon J
    Asia Pac J Clin Oncol; 2012 Mar; 8(1):95-100. PubMed ID: 22369450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiology patient page. Breast cancer chemotherapy and your heart.
    Unitt C; Montazeri K; Tolaney S; Moslehi J
    Circulation; 2014 Jun; 129(25):e680-2. PubMed ID: 24958758
    [No Abstract]   [Full Text] [Related]  

  • 14. Prospective surveillance and management of cardiac toxicity and health in breast cancer survivors.
    Schmitz KH; Prosnitz RG; Schwartz AL; Carver JR
    Cancer; 2012 Apr; 118(8 Suppl):2270-6. PubMed ID: 22488701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for cardiac risk before anthracycline administration: what are the real benefits?
    Ewer MS; Yang M; Buzdar AU
    Clin Breast Cancer; 2012 Feb; 12(1):1-3. PubMed ID: 22130035
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiotoxicity: anthracyclines and long term cancer survivors.
    Patanè S
    Int J Cardiol; 2014 Oct; 176(3):1326-8. PubMed ID: 25129289
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention and management of cardiotoxicity from antineoplastic therapy.
    Chanan-Khan A; Srinivasan S; Czuczman MS
    J Support Oncol; 2004; 2(3):251-6; discussion 259-61, 264-6. PubMed ID: 15328825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiotoxicity associated with trastuzumab treatment of HER2+ breast cancer.
    Fiúza M
    Adv Ther; 2009 Jul; 26 Suppl 1():S9-17. PubMed ID: 19669637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitigating Cardiovascular Dysfunction Across the Cancer Continuum.
    Shelburne NM; Hammer MJ
    Oncol Nurs Forum; 2018 Jan; 45(1):15-17. PubMed ID: 29251286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart matters: cardiovascular complications related to cancer treatment.
    Altena R; van Veldhuisen DJ
    Future Oncol; 2013 Feb; 9(2):137-40. PubMed ID: 23414462
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.